Markets.News

AXGN  AXOGEN INC

+ add to watchlist

$23.55

it's time to rethink nerve repair! axogen (nasdaq: axgn) is a medical products company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. people suffer traumatic injuries or undergo surgeries that impact the function of their peripheral nerves daily. damage may cause loss of function and feeling. axogen is bringing the science of nerve repair to life with its avance® nerve graft which axogen believes is the first and only commercially available allograft for bridging nerve discontinuities, axoguard® nerve connector, a coaptation aid allowing for close approximation of severed nerves, and axoguard® nerve protector that protects nerves during the healing process.

Mkt Cap: $1.09B

52 Week High: $24.92

P/E: 0.00

52 Week Low: $9.22

Dividend: $0.00

Shares Outstanding: 46.12M

This news is delayed by 15 minutes, sign up now to get live news & full features.